International Women’s Day: The Gender Health Gap & Medical Bias
International Women’s Day serves as a crucial reminder of persistent inequalities, including a significant gap in medical research focused on conditions uniquely affecting women. Historically, medical science has been built around the male body, leading to a situation where female-specific complaints are often dismissed or diseases are diagnosed too late. A stark example of this disparity is Hyperemesis Gravidarum (HG), a severe form of nausea and vomiting during pregnancy that can confine women to bed for the entirety of their nine months.
The question of why medical science continues to underinvest in research into women’s health conditions is gaining attention. This issue was recently discussed with Dr. Efraim Hart, a physician and researcher at the OLVG hospital in Amsterdam, and journalist Salwa van der Gaag, who personally experienced the debilitating effects of HG, during a segment on the Dutch radio program “Met Mandy!”
The Historical Roots of the Health Gap
The imbalance in medical research isn’t accidental. For decades, clinical trials often excluded women, particularly those of childbearing potential, due to concerns about potential risks to a fetus. This exclusion, while intended to be protective, created a significant data gap. Without sufficient data on how diseases manifest and respond to treatment in women, medical understanding remained skewed towards the male experience. This isn’t simply a matter of fairness; it’s a matter of accurate diagnosis and effective treatment for half the population.
Understanding Hyperemesis Gravidarum
HG is far more than typical “morning sickness.” It’s a potentially life-threatening condition characterized by severe nausea and vomiting, leading to dehydration, malnutrition, and significant weight loss. According to the HER Foundation, a global advocacy and research organization dedicated to HG awareness, the condition can also result in long-term health issues for both mother and baby. Learn more about HG from the HER Foundation. While the exact cause of HG remains unclear, recent research points to a significant role for a substance called GDF15.
As explained by deverloskundige.nl, GDF15 is normally produced by the body in response to toxins, such as those encountered during food poisoning, triggering nausea and vomiting. In pregnancy, levels of GDF15 increase, but in women who develop HG, these levels are exceptionally high, leading to an overwhelming and debilitating response. However, it’s significant to note that elevated GDF15 levels don’t automatically mean someone will develop HG; other factors are likely involved, and research is ongoing.
The Impact on Women’s Lives
The consequences of HG extend far beyond physical discomfort. Women with HG often experience significant disruptions to their daily lives, impacting their ability to operate, care for other children, and maintain social connections. The psychological toll can be immense, with many women experiencing anxiety, depression, and feelings of isolation. The fact that HG is often dismissed as “normal” pregnancy discomfort can exacerbate these feelings, leaving women feeling unheard and unsupported.
Why the Research Lag?
Several factors contribute to the ongoing lack of research into women-specific diseases. Beyond the historical exclusion of women from clinical trials, there’s a perception – often unconscious – that women’s health issues are less “serious” than men’s. Funding for research into conditions like heart disease and cancer, which affect both sexes, often takes precedence. The complexity of the female reproductive system and hormonal fluctuations can make research more challenging and expensive.
As highlighted in a recent report on NPO Radio 1, this bias isn’t limited to pregnancy-related conditions. Many other female-specific conditions, such as endometriosis and polycystic ovary syndrome (PCOS), receive significantly less research funding than comparable male conditions.
What’s Being Done and What Comes Next
Fortunately, awareness of this disparity is growing. Organizations like the HER Foundation are actively advocating for increased research funding and improved clinical care for HG. They offer resources for patients, support for families, and a professional network for healthcare providers. The foundation is also involved in ongoing research trials, including studies in Australia, the UK, and the Philippines.
The HER Foundation also hosts support groups, including an HG Loss Support Group scheduled for March 10, 2026, and a Mindful Eating Support Group on March 16, 2026, demonstrating their commitment to holistic care. Explore upcoming events and resources on the HER Foundation website.
Addressing this imbalance requires a multi-faceted approach. Increased funding for research into women’s health is essential, as is the inclusion of women in all stages of clinical trials. Healthcare providers need to be better educated about women-specific conditions and encouraged to take women’s concerns seriously. Finally, a cultural shift is needed to recognize that women’s health is not a niche issue, but a fundamental aspect of public health.
Looking ahead, continued advocacy, increased research funding, and a commitment to inclusive clinical trials are crucial steps toward closing the health gap and ensuring that all individuals receive the care they deserve. The ongoing work of organizations like the HER Foundation, coupled with growing awareness among healthcare professionals and the public, offers hope for a future where women’s health is prioritized and adequately addressed.